University of Chicago

Gamma Rays from Fast Black-hole Winds (2021) Ajello M, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bellazzini R, Berretta A, et al. Journal article Special Section Guest Editorial: Computed tomography (CT) at 50 years (2021) La Rivière PJ, Fahrig R, Pelc NJ Journal article The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia with New Reporting Recommendations and Approach to Lesions with Mixed and Early Patterns of Neoplasia (2021) Amin MB, Comperat E, Epstein J, True LD, Hansel D, Paner GP, Al-Ahmadie H, et al. Journal article, Review article The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers (2021) Comperat E, Amin MB, Epstein J, Hansel DE, Pane G, Al-Ahmadie H, True L, et al. Journal article, Review article The 2021 flexible and printed electronics roadmap (2021) Bonnassieux Y, Brabec C, Cao Y, Carmichael TB, Chabinyc ML, Cheng KT, Cho G, et al. Journal article, Review article Design and sensitivity of the Radio Neutrino Observatory in Greenland (RNO-G) (2021) Aguilar JA, Allison P, Beatty JJ, Bernhoff H, Besson D, Bingefors N, Botner O, et al. Journal article Detection of the Crab Nebula with the 9.7 m prototype Schwarzschild-Couder telescope (2021) Adams CB, Alfaro R, Ambrosi G, Ambrosio M, Aramo C, Arlen T, Batista PI, et al. Journal article The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13. (2021) Zanetti C, Kumar R, Ender J, Godavarthy PS, Hartmann M, Hey J, Breuer K, et al. Journal article Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop. (2021) Cho Y, Tong A, Craig JC, Mustafa RA, Chapman A, Perrone RD, Ahn C, et al. Journal article PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution